Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Guelph

$29,000.00

Characterization and manipulation of bacterial microbiomes in domestic animals

FY 2014-15

Summary
Animals harbour complex, diverse and typically poorly defined microbial populations at various body sites. While poorly defined, it is clear that these populations (the microbiota) and the sum of their genetic elements and interactions (the microbiome) play critical roles in both development and prevention of various diseases, including disease not classically considered to be infectious. New technologies have revolutionized our understanding of the body's microbiomes, thereby creating unique opportunities for development and testing of novel and non-antimicrobial preventive and therapeutic methods for animals. The potential for safe and effective biotherapeutic (microbial-based) approaches for prevention or treatment of disease is highly appealing, particularly given the epidemic of antimicrobial resistance that is both limiting available treatment options and increasing scrutiny of antimicrobial use in animals. Yet, only with proper understanding of the host's 'normal' microbial population can biotherapeutic approaches be properly developed and evaluated. This program will characterize the microbiomes of different anatomical sites of selected domestic animal species, something that will provide important information to help understand how these populations develop and how they can be modified. It will complement preliminary microbiome studies being performed by the Applicant, and his laboratory's expertise in infectious diseases, gastroenterology and probiotic therapy. This program will use recent advances in next generation sequencing and bioinformatics to describe and compare selected microbiomes in piglets, foals and dogs, and to explore the use of biotherapeutic approaches to treatment or prevention of disease. Specific objectives of this program are to characterize development of the fecal microbiome of foals and piglets, to evaluate the effect of fecal transplantation on the development foal and piglet intestinal microbiomes, to evaluate different approaches to fecal transplantation, to characterize the vaginal microbiome of healthy dogs and dogs with recurrent urinary tract infections (UTIs) to enable development of a potential biotherapeutic approach for prevention of recurrent UTIs.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
385805-2013
Name nom
Weese, Scott
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
2
Nb partie
5
Application title
Characterization and manipulation of bacterial microbiomes in domestic animals
Keyword
NSERC
Application summary
Animals harbour complex, diverse and typically poorly defined microbial populations at various body sites. While poorly defined, it is clear that these populations (the microbiota) and the sum of their genetic elements and interactions (the microbiome) play critical roles in both development and prevention of various diseases, including disease not classically considered to be infectious. New technologies have revolutionized our understanding of the body's microbiomes, thereby creating unique opportunities for development and testing of novel and non-antimicrobial preventive and therapeutic methods for animals. The potential for safe and effective biotherapeutic (microbial-based) approaches for prevention or treatment of disease is highly appealing, particularly given the epidemic of antimicrobial resistance that is both limiting available treatment options and increasing scrutiny of antimicrobial use in animals. Yet, only with proper understanding of the host's 'normal' microbial population can biotherapeutic approaches be properly developed and evaluated. This program will characterize the microbiomes of different anatomical sites of selected domestic animal species, something that will provide important information to help understand how these populations develop and how they can be modified. It will complement preliminary microbiome studies being performed by the Applicant, and his laboratory's expertise in infectious diseases, gastroenterology and probiotic therapy. This program will use recent advances in next generation sequencing and bioinformatics to describe and compare selected microbiomes in piglets, foals and dogs, and to explore the use of biotherapeutic approaches to treatment or prevention of disease. Specific objectives of this program are to characterize development of the fecal microbiome of foals and piglets, to evaluate the effect of fecal transplantation on the development foal and piglet intestinal microbiomes, to evaluate different approaches to fecal transplantation, to characterize the vaginal microbiome of healthy dogs and dogs with recurrent urinary tract infections (UTIs) to enable development of a potential biotherapeutic approach for prevention of recurrent UTIs.